A bipartisan bill that aimed to give FDA authority to require sponsors of pediatric cancer trials study a combination of drugs, rather than one drug at a time, in order to speed development of drugs that treat relapsed cancer did not make it into the year-end spending package. Reps. G. K. Butterfield (D-NC) and Michael McCaul’s (R-TX) Give Kids a Chance Act (H.R. 5416) was included in the House-passed user fee bill earlier this year, but it was pulled out...